Users online: 3465    [ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2019, Volume : 12, Issue : 2
First page : ( 669) Last page : ( 677)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2019.00119.7

Formulation and Evaluation of Mucoadhesive Microspheres of Valsartan

Saisree R.1, Bhanja Satyabrata1,*, Das Swarup1, Bhavana V1, Sudhakar M.1, Panigrahi B.B2

1Department of Pharmaceutics, Mallareddy College of Pharmacy (Affiliated to Osmania University), Telangana State

2Hi-tech College of Pharmacy, Bhubaneswar, Odisha

*Corresponding Author E-mail: satyabrata_bhanja@rediffmail.com

Online published on 18 April, 2019.


The objective of the present study is to reduce dosing frequency and improve patient compliance by designing and systematically evaluating mucoadhesive microspheres of valsartan. Frequent administration and variable low bioavailability (20–25%) after oral administration are problems of conventional dosage forms of valsartan. This can be attenuated by designing it in form of mucoadhesive microspheres which would prolong the residence time at the absorption site to facilitate intimate contact with absorption surface and thereby improve and enhance bioavailability. Valsartan microspheres were formulated by Emulsion Solvent Evaporation technique using polymers i.e. Xanthum Gum, Tragacanth, Carbopol 940 and HPMC K4M. All the formulations (F1-F12) were subjected to Percentage yield, Entrapment efficiency, Particle size analysis, Loose surface crystallography, Swelling index, Mucoadhesion test, In-vitro drug release studies and Scanning electron microscopy. FTIR data indicates that there was no drug interaction between drug and polymers used. Scanning electron microscopy indicated that microspheres (289±2.28μm-399±3.12μm) were spherical in shape and drug remained dispersed in polymer matrix. Among all formulations, the formulation F12 displayed better result whose Percentage yield (98.6%), Entrapment efficiency (88.9±0.17%), Swelling index (78.8±1.84mg) and In-vitro drug release was found to be 95±0.24% after 12 hours. The formulation F12 is following zero-order kinetics with non-fickian diffusion mechanism. Based on all the above evaluation parameters it was concluded that the formulation F12 was found to be the best formulation among all the formulations and can be used in the treatment of Hypertension.



Mucoadhesive Microspheres, Entrapment efficiency, Swelling index, Mucoadhesion test, In-vitro drug release studies.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
451,388,788 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.